Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study

Published 2013 View Full Article

Authors

Keywords

Breast cancer, Recombinant human endostatin, Neoadjuvant chemotherapy, Clinical trial

Journal

BMC CANCER

Volume 13, Issue 1, Pages -

Publisher

Springer Nature

Online

2013-05-22

DOI

10.1186/1471-2407-13-248

References

View 4 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now